In case you missed it: August 22 to August 26
A look back at the week's top headlines.
FDA grants emergency use of Novavax COVID-19 vaccine, adjuvanted in patients 12 years and older
Novavax joins the growing list of COVID-19 vaccines including vaccines from Pfizer-BioNTech, Moderna, and Johnson & Johnson’s Janssen
FDA expands approval of Mirena for up to 8 years
After a recent FDA approval, Mirena can be used to prevent pregnancy for up to 8 years.
Gestational diabetes mellitus rate increased from 2016 to 2020
Data from the US Department of Health and Human Services has shown an increase in GDM rate from 2016 to 2020, with a greater increase observed from 2019 to 2020.
March of Dimes launches new preterm birth research center at UCSF
Marina Sirota, PhD, associate professor of pediatrics at the University of California, San Francisco, spoke about the new March of Dimes Prematurity Research Center at UCSF and the impact they hope their research will have on the future of preterm birth.
Short menstrual cycles may predict earlier menopause, worse symptoms in midlife
Women with shorter menstrual cycles may reach menopause earlier and experience more severe symptoms overall, according to research in Menopause.
SART data indicates rise in IVF use in 2022
April 24th 2024Dive into the latest statistics from the Society for Assisted Reproductive Technology, revealing a 6% increase in in vitro fertilization cycles and a surge in egg freezing, amidst a landscape of rising fertility service demand and evolving clinical practices.
Read More
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More
